H
Hugh M. Shingleton
Researcher at University of Alabama at Birmingham
Publications - 136
Citations - 5608
Hugh M. Shingleton is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Cervix & Carcinoma. The author has an hindex of 37, co-authored 136 publications receiving 5486 citations. Previous affiliations of Hugh M. Shingleton include Carolinas Medical Center & University of Washington.
Papers
More filters
Journal ArticleDOI
Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling
Larry C. Kilgore,Edward E. Partridge,Ronald D. Alvarez,J.Maxwell Austin,Hugh M. Shingleton,Frank Noojin,Wendy Conner +6 more
TL;DR: The significant survival advantage for patients having multiple-site pelvic node sampling, overall and in high- and low-risk groups, strongly suggests a therapeutic benefit in patients with adenocarcinoma of the endometrium.
Journal ArticleDOI
Results and complications of operative staging in cervical cancer: Experience of the Gynecologic Oncology Group
TL;DR: It is still not clear how many patients can be salvaged by treatment to extended paraaortic radiation fields, but longer periods of follow-up in patients whose treatment plans were based on surgical staging information will be required.
Journal ArticleDOI
Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
TL;DR: Cis‐platinum appears to be a highly active agent in the treatment of squamous cell carcinoma of the cervix at the dose and schedule tested.
Journal ArticleDOI
Hydroxyurea or placebo combined with radiation to treat stages iiib and iv cervical cancer confined to the pelvis
Myroslaw M. Hreshchyshyn,Bernard S. Aron,Bernard S. Aron,Richard C. Boronow,Ernest W. Franklin,Hugh M. Shingleton,John A. Blessing +6 more
TL;DR: Patients with cervical squamous cell carcinoma Stages IIIB and IVA were randomly assigned to treatment with hydroxyurea or placebo in combination with radiation, and response was significantly better in the groups of patients receiving hydroxyUREa.
Journal Article
Endometrial cancer, obesity, and body fat distribution.
TL;DR: A strong, positive relationship between overall obesity and endometrial cancer was found and there was a statistically significant, independent positive effect of a high subscapular to tricep skinfold ratio, a measure of central versus peripheral obesity, on endometrian cancer risk.